<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">22065255</PMID>
        <DateCompleted>
            <Year>2012</Year>
            <Month>01</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-3636</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>68</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2011</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Archives of general psychiatry</Title>
                <ISOAbbreviation>Arch. Gen. Psychiatry</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1238-46</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/archgenpsychiatry.2011.121</ELocationID>
            <Abstract>
                <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">No randomized trials have examined treatments for prescription opioid dependence, despite its increasing prevalence.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the efficacy of brief and extended buprenorphine hydrochloride-naloxone hydrochloride treatment, with different counseling intensities, for patients dependent on prescription opioids.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">Multisite, randomized clinical trial using a 2-phase adaptive treatment research design. Brief treatment (phase 1) included 2-week buprenorphine-naloxone stabilization, 2-week taper, and 8-week postmedication follow-up. Patients with successful opioid use outcomes exited the study; unsuccessful patients entered phase 2: extended (12-week) buprenorphine-naloxone treatment, 4-week taper, and 8-week postmedication follow-up.</AbstractText>
                <AbstractText Label="SETTING" NlmCategory="METHODS">Ten US sites. Patients A total of 653 treatment-seeking outpatients dependent on prescription opioids.</AbstractText>
                <AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">In both phases, patients were randomized to standard medical management (SMM) or SMM plus opioid dependence counseling; all received buprenorphine-naloxone.</AbstractText>
                <AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Predefined &quot;successful outcome&quot; in each phase: composite measures indicating minimal or no opioid use based on urine test-confirmed self-reports.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">During phase 1, only 6.6% (43 of 653) of patients had successful outcomes, with no difference between SMM and SMM plus opioid dependence counseling. In contrast, 49.2% (177 of 360) attained successful outcomes in phase 2 during extended buprenorphine-naloxone treatment (week 12), with no difference between counseling conditions. Success rates 8 weeks after completing the buprenorphine-naloxone taper (phase 2, week 24) dropped to 8.6% (31 of 360), again with no counseling difference. In secondary analyses, successful phase 2 outcomes were more common while taking buprenorphine-naloxone than 8 weeks after taper (49.2% [177 of 360] vs 8.6% [31 of 360], P &lt; .001). Chronic pain did not affect opioid use outcomes; a history of ever using heroin was associated with lower phase 2 success rates while taking buprenorphine-naloxone.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prescription opioid-dependent patients are most likely to reduce opioid use during buprenorphine-naloxone treatment; if tapered off buprenorphine-naloxone, even after 12 weeks of treatment, the likelihood of an unsuccessful outcome is high, even in patients receiving counseling in addition to SMM.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Weiss</LastName>
                    <ForeName>Roger D</ForeName>
                    <Initials>RD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA. rweiss@mclean.harvard.edu</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Potter</LastName>
                    <ForeName>Jennifer Sharpe</ForeName>
                    <Initials>JS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fiellin</LastName>
                    <ForeName>David A</ForeName>
                    <Initials>DA</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Byrne</LastName>
                    <ForeName>Marilyn</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Connery</LastName>
                    <ForeName>Hilary S</ForeName>
                    <Initials>HS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dickinson</LastName>
                    <ForeName>William</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gardin</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Griffin</LastName>
                    <ForeName>Margaret L</ForeName>
                    <Initials>ML</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gourevitch</LastName>
                    <ForeName>Marc N</ForeName>
                    <Initials>MN</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haller</LastName>
                    <ForeName>Deborah L</ForeName>
                    <Initials>DL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hasson</LastName>
                    <ForeName>Albert L</ForeName>
                    <Initials>AL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Zhen</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacobs</LastName>
                    <ForeName>Petra</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kosinski</LastName>
                    <ForeName>Andrzej S</ForeName>
                    <Initials>AS</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lindblad</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McCance-Katz</LastName>
                    <ForeName>Elinore F</ForeName>
                    <Initials>EF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Provost</LastName>
                    <ForeName>Scott E</ForeName>
                    <Initials>SE</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Selzer</LastName>
                    <ForeName>Jeffrey</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Somoza</LastName>
                    <ForeName>Eugene C</ForeName>
                    <Initials>EC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sonne</LastName>
                    <ForeName>Susan C</ForeName>
                    <Initials>SC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ling</LastName>
                    <ForeName>Walter</ForeName>
                    <Initials>W</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT00316277</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2U10DA020036</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>K24 DA022288-05</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA015831</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA013035</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>2U10DA013714</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>UG1 DA015815</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>2U10DA013035</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>K24 DA023359</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>K23 DA022297</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA020036</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>HHSN2712005220HC</GrantID>
                    <Acronym>HC</Acronym>
                    <Agency>NHLBI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>HHSN271200522081C</GrantID>
                    <Agency>PHS HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA015831-10</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>HHSN271200522071C</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>5U10DA013732</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>2U10DA015831</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA013714</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>K24 DA022288</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA013732</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>2U10DA015815</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA013045</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>2U10DA013045</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA013727</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>U10 DA015815</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>2U10DA013727</GrantID>
                    <Acronym>DA</Acronym>
                    <Agency>NIDA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016448">Multicenter Study</PublicationType>
                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2011</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Arch Gen Psychiatry</MedlineTA>
            <NlmUniqueID>0372435</NlmUniqueID>
            <ISSNLinking>0003-990X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009292">Narcotic Antagonists</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>36B82AMQ7N</RegistryNumber>
                <NameOfSubstance UI="D009270">Naloxone</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>40D3SCR4GZ</RegistryNumber>
                <NameOfSubstance UI="D002047">Buprenorphine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002047" MajorTopicYN="N">Buprenorphine</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003376" MajorTopicYN="Y">Counseling</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007406" MajorTopicYN="N">Interview, Psychological</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009270" MajorTopicYN="N">Naloxone</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009292" MajorTopicYN="N">Narcotic Antagonists</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058850" MajorTopicYN="N">Opiate Substitution Treatment</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009293" MajorTopicYN="N">Opioid-Related Disorders</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2011</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2011</Year>
                <Month>11</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2012</Year>
                <Month>1</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">22065255</ArticleId>
            <ArticleId IdType="pii">archgenpsychiatry.2011.121</ArticleId>
            <ArticleId IdType="doi">10.1001/archgenpsychiatry.2011.121</ArticleId>
            <ArticleId IdType="pmc">PMC3470422</ArticleId>
            <ArticleId IdType="mid">NIHMS307513</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Intern Med. 1995 Sep 11;155(16):1757-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7654109</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Intern Med. 2007 Apr;22(4):527-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17372805</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2006 May 3;295(17):2003-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16670409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Addiction. 2007 May;102(5):752-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17506152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 2006 Jan;63(1):102-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16389204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2009;(3):CD002209</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19588333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Addict. 2006 May-Jun;15(3):208-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16923666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Alcohol Depend. 2009 Nov 1;105(1-2):154-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19647958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Pain. 2004 Sep-Oct;20(5):309-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15322437</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Addict. 2009 Sep-Oct;18(5):379-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19874157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2003 May 14;289(18):2370-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12746360</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Control Clin Trials. 2004 Feb;25(1):119-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15061154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Contemp Clin Trials. 2010 Mar;31(2):185-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20079463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pain Suppl. 1986;3:S1-226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3461421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Alcohol Depend. 1997 Sep 25;47(3):227-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9306048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 1983 Jun;40(6):639-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6847332</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Addiction. 1998 Jan;93(1):73-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9624713</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Subst Abuse Treat. 2003 Oct;25(3):125-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14670518</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Jul 27;355(4):365-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16870915</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):618-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16862602</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Contemp Clin Trials. 2010 Mar;31(2):189-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20116457</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pain Symptom Manage. 2000 Jan;19(1):53-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10687327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Alcohol Depend. 2007 May;88 Suppl 2:S24-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17056207</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Psychiatry. 2008 Feb;165(2):179-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18198270</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Addict Behav. 2009 Mar;34(3):304-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19081679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biometrics. 1997 Sep;53(3):937-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9290224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Addict. 2010 Mar-Apr;19(2):141-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20163386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Addiction. 2005 Aug;100(8):1090-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16042639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1993 Apr 21;269(15):1953-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8385230</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Alcohol Depend. 2006 May 20;82(3):187-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16219429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 1998 Aug;105(2):100-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9727815</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Subst Abuse Treat. 2010 Sep;39(2):96-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20598829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pain Med. 2011 Apr;12(4):657-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21392250</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>MMWR Morb Mortal Wkly Rep. 2010 Jun 18;59(23):705-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20559200</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2008;(4):CD004147</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18843654</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Gen Psychiatry. 1999 Jun;56(6):493-502</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10359461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Clin Psychopharmacol. 2008 Oct;16(5):435-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18837640</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>